Quantitative analysis of tissue area of endoscopic ultrasound‐guided liver biopsy specimens using 19‐gauge fine‐needle biopsy needle in patients with diffuse liver disease: A single‐center retrospective study

• Published in: Journal of hepato-biliary-pancreatic sciences 2023-05, Vol.30 (5), p.678-685
• Main Authors: Matsumoto, Kotaro, Doi, Shinpei, Watanabe, Ayako, Katsukura, Nobuhiro, Tsujikawa, Takayuki, Takahashi, Mikiko, Kikuchi, Kentaro
• Format: Article
• Language: English
• Subjects: Biopsy; diffuse liver disease; endoscopic ultrasound; Endoscopic Ultrasound-Guided Fine Needle Aspiration - adverse effects; Endoscopic Ultrasound-Guided Fine Needle Aspiration - methods; Endoscopy; Endosonography - methods; fine needle biopsy; Humans; liver biopsy; Liver diseases; Liver Diseases - diagnostic imaging; Liver Diseases - pathology; Quantitative analysis; Retrospective Studies; Success; tissue area; Ultrasonic imaging
• ISSN: 1868-6974; 1868-6982
• DOI: 10.1002/jhbp.1244

Background/Purpose Endoscopic ultrasound‐guided liver biopsy (EUS‐LB) is a novel liver biopsy technique. We aimed to evaluate the efficacy and safety of EUS‐LB in comparison with percutaneous liver biopsy (PLB). Methods This retrospective study evaluated the safety and efficacy of EUS‐LB using a 19‐gauge fine needle biopsy (FNB) needle compared with PLB using a spring‐loaded 16‐gauge needle in patients with diffuse liver disease at our hospital from April 2017 to December 2020. The primary outcomes included the total hepatic tissue surface area and the total number of portal tracts. Secondary outcomes included the success and adverse event rates. Results Twenty patients each underwent EUS‐LB and PLB. There was no statistical difference in the sum of liver tissue surface area (22 mm2 vs 22.6 mm2, P = .910) and the total number of portal tracts (29 vs 25, P = .916). The success rate was 95% (19/20) for EUS‐LB and 100% (20/20) for PLB (P = 1). There were two adverse events in the PLB group but none in the EUS‐LB group (P = .487). Conclusions Endoscopic ultrasound‐guided liver biopsy using FNB has an optimal tissue yield and success rate and is safe compared to PLB. Thus, EUS‐LB may be a new alternative to PLB. Matsumoto and colleagues evaluated the efficacy and safety of endoscopic ultrasound‐guided liver biopsy (EUS‐LB). The surface area and number of portal tracts of samples obtained through EUS‐LB using 19‐gauge needles were equivalent to those from percutaneous liver biopsy; furthermore, EUS‐LB caused no adverse events. EUS‐LB may be a new option for hepatic biopsy.